JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brzezinski, M. R.
Right arrow Articles by Juchau, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brzezinski, M. R.
Right arrow Articles by Juchau, M. R.

Vol. 289, Issue 3, 1648-1653, June 1999

Catalytic Activity and Quantitation of Cytochrome P-450 2E1 in Prenatal Human Brain1

Monica R. Brzezinski, Helene Boutelet-Bochan, Richard E. Person, Alan G. Fantel and Mont R. Juchau

Departments of Pharmacology (M.R.B., H.B.-B., M.R.J.) and Pediatrics (R.E.P., A.G.F.), School of Medicine, University of Washington, Seattle, Washington

Cytochrome P-450 2E1 (CYP2E1) is a readily inducible hemoprotein that catalyzes the oxidation of endogenous compounds and many low molecular weight xenobiotics. As the major component of the microsomal ethanol oxidizing system, it contributes significantly to ethanol metabolism and the formation of the highly reactive metabolite acetaldehyde. The leaky property of this enzyme results in the generation of reactive oxygen species that can induce oxidative stress and cytotoxic conditions deleterious to development. To further investigate the proposed role of CYP2E1 in the etiology of alcohol teratogenesis, the current study focused on the quantification of CYP2E1 in prenatal human brain, a tissue that is highly vulnerable to the damaging effects of ethanol throughout gestation. In microsomal samples prepared from pools of brain tissues, immunoreactive protein was detected by Western blot analysis using enhanced chemiluminescence, whereas functional protein was estimated with an enzymatic assay using p-nitrophenol and an electrochemical detection system. CYP2E1 transcript was consistently detected in RNA samples prepared from individual brain tissues using the ribonuclease protection assay. Quantitative data were collected by scanning densitometry and phosphorimaging technology. There was a dramatic increase in human brain CYP2E1 content around gestational day 50 and a fairly constant level was maintained throughout the early fetal period, until at least day 113. The relatively low levels of the P-450 isoform present in conceptal brain may be sufficient to generate reactive intermediates that elicit neuroembryotoxicity following maternal alcohol consumption.

0022-3565/99/2893-1648$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
J. Shao, P. L. Stapleton, Y. S. Lin, and E. P. Gallagher
Cytochrome P450 and Glutathione S-Transferase mRNA Expression in Human Fetal Liver Hematopoietic Stem Cells
Drug Metab. Dispos., January 1, 2007; 35(1): 168 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
N. SIGNORINI-ALLIBE, B. GONTHIER, F. LAMARCHE, H. EYSSERIC, and L. BARRET
CHRONIC CONSUMPTION OF ETHANOL LEADS TO SUBSTANTIAL CELL DAMAGE IN CULTURED RAT ASTROCYTES IN CONDITIONS PROMOTING ACETALDEHYDE ACCUMULATION
Alcohol Alcohol., May 1, 2005; 40(3): 163 - 171.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. G. McCarver
Applicability of the Principles of Developmental Pharmacology to the Study of Environmental Toxicants
Pediatrics, April 1, 2004; 113(4/S1): 969 - 972.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Gemma, L. Vittozzi, and E. Testai
Metabolism of Chloroform in the Human Liver and Identification of the Competent P450s
Drug Metab. Dispos., March 1, 2003; 31(3): 266 - 274.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. N. Hines and D. G. McCarver
The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 355 - 360.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. G. Barnes and A. A. Weiss
BrkA Protein of Bordetella pertussis Inhibits the Classical Pathway of Complement after C1 Deposition
Infect. Immun., May 1, 2001; 69(5): 3067 - 3072.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Chen, A. G. Fantel, and M. R. Juchau
Catalysis of the 4-Hydroxylation of Retinoic Acids by Cyp3a7 in Human Fetal Hepatic Tissues
Drug Metab. Dispos., September 1, 2000; 28(9): 1051 - 1057.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.